Press Release: BigBear.ai Announces Third Quarter 2025 Results and Definitive Agreement to Acquire Ask Sage

Dow Jones
2025/11/11
   --  Announces definitive agreement to acquire Ask Sage, a fast-growing 
      Generative AI platform for secure distribution of AI models and agentic 
      AI capabilities, built specifically for defense and national security 
      agencies and other highly-regulated sectors. AskSage is expected to 
      deliver annual recurring revenues $(ARR)$ of approximately $25 million in 
      2025 (non-GAAP), demonstrating a year-on-year increase of approximately 
      six times AskSage's 2024 ARR. BigBear.ai will pay a total of $250 million 
      for the whole business, subject to customary adjustments for indebtedness, 
      cash and working capital. 
 
   --  Sequential improvement to the balance sheet and record cash balance of 
      $456.6 million, as of September 30, 2025, positioning the Company to 
      accelerate growth. 
 
   --  BigBear.ai continues to project full-year 2025 revenue between $125 
      million and $140 million. 
MCLEAN, Va.--(BUSINESS WIRE)--November 10, 2025-- 

BigBear.ai Holdings, Inc. (NYSE: BBAI) ("BigBear.ai" or the "Company"), a leader in AI-powered decision intelligence solutions, today announced financial results for the third quarter of 2025 and issued an investor presentation that has been posted to the Investor Relations section of the Company's website.

"Today, I'm thrilled to announce that BigBear.ai has signed a definitive agreement to acquire Ask Sage, a cutting-edge and fast-growing Generative AI platform for secure distribution of AI models and agentic AI capabilities, built specifically for defense and national security agencies and other highly-regulated sectors. Ask Sage already supports more than 100,000 users on 16,000 government teams and across hundreds of commercial companies. It is a turnkey platform that's in production today, at scale, in the environments that matter most," said Kevin McAleenan, CEO of BigBear.ai.

"By integrating Ask Sage with BigBear.ai, we are creating what the market has been asking for: a secure, integrated AI platform that connects software, data, and mission services in one place," continued McAleenan.

"Despite delays resulting from the government shutdown, we believe the potential for new business in the field of border security and defense remains strong, and we expect to see those opportunities, including accelerated spending resulting from the One Big Beautiful Bill, to materialize into contracts next year. BigBear.ai remains in a very strong position to benefit from the important task of delivering cutting-edge secure technology solutions to support national defense and the defense industrial base," continued McAleenan.

"Subject to applicable approvals, we look forward to closing the Ask Sage acquisition and continuing to execute on our M&A strategy to drive rapid growth," said Sean Ricker, CFO of BigBear.ai.

Financial Highlights

   --  Revenue decreased 20% to $33.1 million for the third quarter of 2025, 
      compared to $41.5 million for the third quarter of 2024 primarily due to 
      lower volume on certain Army programs. 
 
   --  Gross margin was 22.4% in the third quarter of 2025, compared to 25.9% 
      in the third quarter of 2024, primarily due to higher margin programs in 
      the third quarter of 2024 that were not repeated in the third quarter of 
      2025. 
 
   --  Net income in the third quarter of 2025 was $2.5 million, compared to a 
      net loss of $15.1 million for the third quarter of 2024. The decrease in 
      net loss was primarily driven by non-cash changes in derivative 
      liabilities of $26.1 million associated with changes in the fair value of 
      the convertible features of the 2029 Notes and warrants, offset by an $8 
      million increase in SG&A. 
 
   --  Non-GAAP Adjusted EBITDA* of $(9.4) million for the third quarter of 
      2025 compared to $0.9 million for the third quarter of 2024, primarily 
      driven by decreased gross margin as well as an increase in SG&A. 
 
   --  SG&A of $25.3 million for the third quarter of 2025 compared to $17.5 
      million for the third quarter of 2024. The year-over-year increase was 
      primarily driven by an increase in marketing of $1.4 million, 
      non-recurring strategic initiatives of $2.0 million and SG&A labor and 
      fringe costs of $4.3 million. 
 
   --  Backlog of $376 million as of September 30, 2025. 

Financial Outlook

For the year-ended December 31, 2025, the Company continues to project:

   --  Revenue between $125 million and $140 million 

The anticipated acquisition of Ask Sage, Inc. is expected to close late in the fourth quarter of 2025 or early in the first quarter of 2026 and therefore, the Company does not expect the financial results of the acquisition to have a material impact on the Company's consolidated 2025 financial results.

The above information on financial outlook, and other sections of this release contain forward-looking statements, which are based on the Company's current expectations. Actual results may differ materially from those projected. It is the Company's practice not to incorporate adjustments into its financial outlook for proposed acquisitions, divestitures, changes in law, or new accounting standards until such items have been consummated, enacted, or adopted, as the case may be. For additional factors that may impact the Company's actual results, refer to the "Forward-Looking Statements" section in this release.

 
*EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin are non-GAAP financial 
measures. See the "Non-GAAP Financial Measures" section in this press release 
for additional information and reconciliations. 
 
 
 
 
 
                 Summary of Results for the Third Quarter Ended 
                    September 30, 2025 and September 30, 2024 
                                   (Unaudited) 
 
                          Three Months Ended             Nine Months Ended 
                             September 30,                  September 30, 
                     ----------------------------  ------------------------------ 
$ thousands (expect 
per share amounts)       2025           2024           2025           2024 
-------------------   -----------    -----------    -----------    ----------- 
Revenues             $     33,143   $     41,505   $    100,372   $    114,409 
Cost of revenues           25,714         30,739         77,442         85,594 
-------------------   -----------    -----------    -----------    ----------- 
    Gross margin            7,429         10,766         22,930         28,815 
Operating expenses: 
    Selling, 
     general and 
     administrative        25,255         17,485         69,474         57,797 
    Research and 
     development            3,375          3,820         11,934          8,529 
    Restructuring 
     charges                  660             --          4,257          1,317 
    Transaction 
     expenses                  --             --             --          1,450 
    Goodwill 
     impairment                --             --         70,636         85,000 
-------------------   -----------    -----------    -----------    ----------- 
Operating loss            (21,861)       (10,539)      (133,371)      (125,278) 
    Interest 
     expense                4,604          6,552         14,139         19,389 
    Net (decrease) 
     increase in 
     fair value of 
     derivatives          (26,125)        (1,330)       142,962         14,396 
    Loss on 
    extinguishment 
    of debt                    --             --          2,577             -- 
    Other income, 
     net                   (2,878)          (647)        (5,021)        (1,719) 
-------------------   -----------    -----------    -----------    ----------- 
Income (loss) 
 before taxes               2,538        (15,114)      (288,028)      (157,344) 
    Income tax 
     expense                   17             21             56             22 
-------------------   -----------    -----------    -----------    ----------- 
Net income (loss)    $      2,521   $    (15,135)  $   (288,084)  $   (157,366) 
-------------------   -----------    -----------    -----------    ----------- 
 
Basic net income 
 (loss) per share    $       0.01   $      (0.06)  $      (0.87)  $      (0.69) 
Diluted net loss 
 per share           $      (0.03)  $      (0.06)  $      (0.87)  $      (0.69) 
 
Weighted-average 
shares 
outstanding: 
    Basic             396,589,354    249,951,542    331,973,873    227,900,950 
    Diluted           448,158,249    249,951,542    331,973,873    227,900,950 
-------------------   -----------    -----------    -----------    ----------- 
 
 
 
 
 
 
                    Consolidated Balance Sheets as of 
                 September 30, 2025 and December 31, 2024 
                                (Unaudited) 
 
$ in thousands (except per share          September 30,     December 31, 
amounts)                                       2025             2024 
---------------------------------------  ---------------  ---------------- 
Assets 
Current assets: 
    Cash and cash equivalents             $     456,580    $     50,141 
    Held-to-maturity investments, net           130,084              -- 
    Accounts receivable, less allowance 
     for credit losses                           24,371          38,953 
    Contract assets                               2,180             895 
    Prepaid expenses and other current 
     assets                                       6,546           3,768 
---------------------------------------      ----------       --------- 
Total current assets                            619,761          93,757 
---------------------------------------      ----------       --------- 
Non-current assets: 
    Property and equipment, net                   1,439           1,566 
    Goodwill                                     48,446         119,081 
    Intangible assets, net                      112,670         119,119 
    Held-to-maturity investments, net           128,780              -- 
    Right-of-use assets                           7,309           9,263 
    Other non-current assets                      1,351             990 
---------------------------------------      ----------       --------- 
Total assets                              $     919,756    $    343,776 
---------------------------------------      ----------       --------- 
 
Liabilities and stockholders' equity 
(deficit) 
Current liabilities: 
    Accounts payable                      $       5,577    $      8,455 
    Short-term debt, including current 
     portion of long-term debt                       --             818 
    Accrued liabilities                          18,299          19,496 
    Contract liabilities                          3,507           2,541 
    Current portion of long-term lease 
     liability                                    1,073           1,068 
    Derivative liabilities                      167,075         170,515 
    Other current liabilities                     2,392              73 
---------------------------------------      ----------       --------- 
Total current liabilities                       197,923         202,966 
---------------------------------------      ----------       --------- 
Non-current liabilities: 
    Long-term debt, net                         104,852         135,404 
    Long-term lease liability                     6,965           9,120 
---------------------------------------      ----------       --------- 
Total liabilities                               309,740         347,490 
---------------------------------------      ----------       --------- 
Stockholders' equity (deficit) 
    Common stock, par value $0.0001; 
     500,000,000 shares authorized and 
     435,777,718 shares issued and 
     outstanding at September 30, 2025 
     and 251,554,378 shares issued and 
     outstanding at December 31, 2024                46              26 
    Additional paid-in capital                1,527,239         625,130 
    Treasury stock, at cost 9,952,803 
     shares at September 30, 2025 and 
     December 31, 2024                          (57,350)        (57,350) 
    Accumulated deficit                        (859,725)       (571,641) 
    Accumulated other comprehensive 
     (loss) income                                 (194)            121 
---------------------------------------      ----------       --------- 
Total stockholders' equity (deficit)            610,016          (3,714) 
Total liabilities and stockholders' 
 equity                                   $     919,756    $    343,776 
---------------------------------------      ----------       --------- 
 
 
 
 
 
 
  Consolidated Statements of Cash Flows for the Nine Months Ended 
              September 30, 2025 and September 30, 2024 
                             (Unaudited) 
 
                      Three Months Ended       Nine Months Ended 
                         September 30,            September 30, 
                     ---------------------  ------------------------ 
$ in thousands          2025       2024        2025        2024 
-------------------   --------    -------    --------    -------- 
Cash flows from 
operating 
activities: 
Net income (loss)    $   2,521   $(15,135)  $(288,084)  $(157,366) 
Adjustments to 
reconcile net loss 
to net cash used in 
operating 
activities: 
    Depreciation 
     and 
     amortization 
     expense             4,127      3,394      11,048       8,740 
    Amortization of 
     debt discount 
     and issuance 
     costs               2,159      3,516       6,949      10,259 
    Amortization of 
     discount on 
     HTM 
     investments          (125)        --        (125)         -- 
    Equity-based 
     compensation 
     expense             5,321      5,168      17,040      16,074 
    Goodwill 
     impairment             --         --      70,636      85,000 
    Non-cash lease 
     expense             1,330        190       1,954         553 
    Provision for 
     doubtful 
     accounts               --         44         351         220 
    Deferred income 
     tax benefit            --         --          --         (37) 
    Loss on 
    extinguishment 
    of debt                 --         --       2,577          -- 
    (Decrease) 
     increase in 
     fair value of 
     derivatives       (26,125)    (1,330)    142,962      14,396 
Changes in assets 
and liabilities: 
    Decrease 
     (increase) in 
     accounts 
     receivable          3,972        836      14,239      (5,396) 
    (Increase) 
     decrease in 
     contract 
     assets             (1,479)      (703)     (1,285)      3,078 
    (Increase) 
     decrease in 
     prepaid 
     expenses and 
     other assets       (2,546)       297      (3,138)      1,540 
    Increase 
     (decrease) in 
     accounts 
     payable             2,150     (3,177)     (2,889)     (8,224) 
    Increase in 
     accrued 
     expenses            1,749      5,958       6,514       7,610 
    (Decrease) 
     increase in 
     contracts 
     liabilities          (959)      (983)        966         486 
    (Decrease) 
     increase in 
     other 
     liabilities        (1,680)        29         168        (246) 
-------------------   --------    -------    --------    -------- 
Net cash used in 
 operating 
 activities             (9,585)    (1,896)    (20,117)    (23,313) 
-------------------   --------    -------    --------    -------- 
Cash flows from 
investing 
activities: 
    Purchases of 
     HTM 
     investments      (258,739)        --    (258,739)         -- 
    Acquisition of 
     business, net 
     of cash 
     acquired               --         --          --      13,935 
    Purchases of 
     property and 
     equipment            (188)      (137)       (273)       (304) 
    Capitalized 
     software 
     development 
     costs              (1,142)    (4,171)     (3,841)     (7,396) 
-------------------   --------    -------    --------    -------- 
Net cash (used in) 
 provided by 
 investing 
 activities           (260,069)    (4,308)   (262,853)      6,235 
-------------------   --------    -------    --------    -------- 
Cash flows from 
financing 
activities: 
    Proceeds from 
     issuance of 
     shares for 
     exercised RDO 
     and PIPE 
     warrants               --         --      64,673      53,809 
    Payment of RDO 
     and PIPE 
     transaction 
     costs                  --         --        (551)         -- 
    Proceeds from 
     at-the-market 
     offerings         337,073         --     637,073          -- 
    Payment of 
     transaction 
     costs for 
     at-the-market 
     offerings          (3,034)        --      (8,284)         -- 
    Repayment of 
     short-term 
     borrowings           (367)      (417)       (818)     (1,229) 
    Payment of debt 
     issuance costs 
     to third 
     parties                --         --      (4,679)         -- 
    Proceeds from 
     exercise of 
     options             1,971         --       3,604         119 
    Issuance of 
     common stock 
     upon ESPP 
     purchase               --         --       1,069         607 
    Payments of tax 
     withholding 
     from the 
     issuance of 
     common stock         (358)        (3)     (2,037)     (3,143) 
-------------------   --------    -------    --------    -------- 
Net cash provided 
 by (used in) 
 financing 
 activities            335,285       (420)    690,050      50,163 
-------------------   --------    -------    --------    -------- 
Effect of foreign 
 currency rate 
 changes on cash 
 and cash 
 equivalents               104        (58)       (641)        (58) 
Net increase 
 (decrease) in cash 
 and cash 
 equivalents            65,735     (6,682)    406,439      33,027 
Cash and cash 
 equivalents at the 
 beginning of the 
 period                390,845     72,266      50,141      32,557 
-------------------   --------    -------    --------    -------- 
Cash and cash 
 equivalents at the 
 end of the period   $ 456,580   $ 65,584   $ 456,580   $  65,584 
-------------------   --------    -------    --------    -------- 
 
 
 
 
 
 
      EBITDA* and Adjusted EBITDA* for the Third Quarter Ended 
              September 30, 2025 and September 30, 2024 
                             (Unaudited) 
 
                       Three Months Ended      Nine Months Ended 
                          September 30,           September 30, 
                      --------------------  ------------------------ 
$ thousands             2025       2024        2025        2024 
--------------------   -------    -------    --------    -------- 
Net income (loss)     $  2,521   $(15,135)  $(288,084)  $(157,366) 
Interest expense         4,604      6,552      14,139      19,389 
Interest income         (4,306)      (635)     (6,566)     (1,807) 
Income tax expense          17         21          56          22 
Depreciation and 
 amortization            4,127      3,394      11,048       8,740 
--------------------   -------    -------    --------    -------- 
EBITDA                   6,963     (5,803)   (269,407)   (131,022) 
Adjustments: 
    Equity-based 
     compensation        5,321      5,168      17,040      16,074 
    Employer payroll 
     taxes related 
     to equity-based 
     compensation(1)       260         29       1,886         741 
    Net increase 
     (decrease) in 
     fair value of 
     derivatives(2)    (26,125)    (1,330)    142,962      14,396 
    Restructuring 
     charges(3)            660         --       4,257       1,317 
    Non-recurring 
     strategic 
     initiatives(4)      3,520      1,568       5,131       4,942 
    Non-recurring 
     litigation(5)          --        574          30       1,119 
    Transaction 
     expenses(6)            --         --          --       1,450 
    Non-recurring 
     integration 
     costs(7)               --        742          --       1,625 
    Goodwill 
     impairment(8)          --         --      70,636      85,000 
    Loss on 
    extinguishment 
    of debt(9)              --         --       2,577          -- 
--------------------   -------    -------    --------    -------- 
Adjusted EBITDA       $ (9,401)  $    948   $ (24,888)  $  (4,358) 
--------------------   -------    -------    --------    -------- 
 
 
(1)   Includes employer payroll taxes due upon the vesting of equity awards 
      granted to employees. 
(2)   The change in fair value of derivatives during the three months ended 
      September 30, 2025 relates to the remeasurement of the 2025 warrants, 
      IPO warrants and the 2026 and 2029 Notes Conversion Options derivative 
      liabilities. The change during the nine months ended September 30, 2025, 
      relates to the $14.0 million loss recorded upon the exercise of the 2024 
      RDO and 2024 PIPE Warrants (the "2024 Warrants") and issuance of the 
      warrants in 2025 (the "2025 Warrants") in connection with the warrant 
      exercise agreements entered into on February 5, 2025. During the nine 
      months ended September 30, 2025, there was loss related to a 
      mark-to-market adjustment of $59.9M adjustment for the debt to equity 
      conversions during the period. There was a loss related to the fair 
      market value adjustment on the 2025 warrants and the private warrants of 
      $1.4 million. Additionally, there was a loss of $28.6 million and $2.3 
      million fair market value adjustments of the 2026 and 2029 Notes 
      Conversion Options, respectively during the nine months ended September 
      30, 2025. The increase in fair value of derivatives during the nine 
      months ended September 30, 2024, relates to the $42.3 million loss 
      recorded upon the exercise of the 2023 RDO and 2023 PIPE Warrants 
      (collectively, the "2023 Warrants") and issuance of the warrants in 2024 
      (the "2024 Warrants") in connection with the warrant exercise agreements 
      entered into on February 27, 2024 and March 4, 2024. This loss is net of 
      a $10.6 million gain related to the issuance of the 2024 Warrants and 
      was further offset by a reduction of $27.4 million upon remeasurement of 
      the 2024 Warrants and IPO Warrants' fair value during the nine months 
      ended September 30, 2024. The decrease in fair value of derivatives 
      during the three months ended September 30, 2024 relates to 
      remeasurement of the 2024 Warrants and IPO Warrants' fair value. 
(3)   During the three and nine months ended September 30, 2025 and September 
      30, 2024, the Company incurred employee separation costs associated with 
      a strategic review of the Company's capacity and future projections to 
      better align the organization and cost structure and improve the 
      affordability of its products and services. 
(4)   Non-recurring professional fees incurred in connection with discrete, 
      non-recurring strategic initiatives, including business transformation 
      and strategy realignment consulting services which management does not 
      consider part of the Company's ongoing operating expenses. 
(5)   Non-recurring litigation consists primarily of legal settlements and 
      related fees for specific proceedings that we have determined arise 
      outside of the ordinary course of business based on the following 
      considerations which we assess regularly: (1) the frequency of similar 
      cases that have been brought to date, or are expected to be brought 
      within two years; (2) the complexity of the case; (3) the nature of the 
      remedy(ies) sought, including the size of any monetary damages sought; 
      (4) offensive versus defensive posture of us; (5) the counterparty 
      involved; and (6) our overall litigation strategy. 
(6)   Transaction expenses during the nine months ended March 31, 2024 consist 
      primarily of diligence, legal and other related expenses incurred 
      associated with the Pangiam acquisition. 
(7)   Non-recurring internal integration costs related to the Pangiam 
      acquisition. 
(8)   During the three months ended March 31, 2024, the Company recognized a 
      non-cash goodwill impairment charge primarily driven by a decrease in 
      share price during the quarter compared to the share price of the equity 
      issued as consideration for the purchase of Pangiam. During the six 
      months ended June 30, 2025, the company recognized a non-cash goodwill 
      impairment charge of $70.6 million, primarily driven by a change in 
      forecast during the second quarter of 2025. 
(9)   Loss on extinguishment of debt is related to voluntary conversions of 
      the 2029 Notes to common stock and the related extinguishment of 
      unamortized debt discount and debt costs. 
 
*EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin are non-GAAP financial 
measures. See the "Non-GAAP Financial Measures" section in this press release 
for additional information and reconciliations. 
 
 
 
 
 
 
         Adjusted EBITDA* Reconciliation for the Third Quarter Ended 
                   September 30, 2025 and September 30, 2024 
                                  (Unaudited) 
 
                          Three Months Ended           Nine Months Ended 
                             September 30,                September 30, 
                      --------------------------  ---------------------------- 
$ in thousands          2025          2024           2025           2024 
--------------------   -------       -------       --------       -------- 
Revenue               $ 33,143      $ 41,505      $ 100,372      $ 114,409 
 
Net income (loss)        2,521       (15,135)      (288,084)      (157,366) 
Interest expense         4,604         6,552         14,139         19,389 
Interest income         (4,306)         (635)        (6,566)        (1,807) 
Income tax expense          17            21             56             22 
Depreciation and 
 amortization            4,127         3,394         11,048          8,740 
--------------------   -------       -------       --------       -------- 
EBITDA*               $  6,963      $ (5,803)     $(269,407)     $(131,022) 
 
Adjustments: 
-------------------- 
    Equity-based 
     compensation        5,321         5,168         17,040         16,074 
    Employer payroll 
     taxes related 
     to equity-based 
     compensation(1)       260            29          1,886            741 
    Net (decrease) 
     increase in 
     fair value of 
     derivatives(2)    (26,125)       (1,330)       142,962         14,396 
    Restructuring 
     charges(3)            660            --          4,257          1,317 
    Non-recurring 
     strategic 
     initiatives(4)      3,520         1,568          5,131          4,942 
    Non-recurring 
     litigation(5)          --           574             30          1,119 
    Transaction 
     expenses(6)            --            --             --          1,450 
    Non-recurring 
     integration 
     costs(7)               --           742             --          1,625 
    Goodwill 
     impairment(8)          --            --         70,636         85,000 
    Loss on 
    extinguishment 
    of debt(9)              --            --          2,577             -- 
--------------------   -------       -------       --------       -------- 
Adjusted EBITDA*      $ (9,401)     $    948      $ (24,888)     $  (4,358) 
Gross Margin              22.4%         25.9%          22.8%          25.2% 
Net Loss Margin            7.6%        (36.5)%       (287.0)%       (137.5)% 
Adjusted EBITDA* 
 Margin                  (28.4)%         2.3%         (24.8)%         (3.8)% 
--------------------   -------       -------       --------       -------- 
 
 
(1)   Includes employer payroll taxes due upon the vesting of equity awards 
      granted to employees. 
(2)   The change in fair value of derivatives during the three months ended 
      September 30, 2025 relates to the remeasurement of the 2025 warrants, 
      IPO warrants and the 2026 and 2029 Notes Conversion Options derivative 
      liabilities. The change during the nine months ended September 30, 2025, 
      relates to the $14.0 million loss recorded upon the exercise of the 2024 
      RDO and 2024 PIPE Warrants (the "2024 Warrants") and issuance of the 
      warrants in 2025 (the "2025 Warrants") in connection with the warrant 
      exercise agreements entered into on February 5, 2025. During the nine 
      months ended September 30, 2025, there was loss related to a 
      mark-to-market adjustment of $59.9M adjustment for the debt to equity 
      conversions during the period. There was a loss related to the fair 
      market value adjustment on the 2025 warrants and the private warrants of 
      $1.4 million. Additionally, there was a loss of $28.6 million and $2.3 
      million fair market value adjustments of the 2026 and 2029 Notes 
      Conversion Options, respectively during the nine months ended September 
      30, 2025. The increase in fair value of derivatives during the nine 
      months ended September 30, 2024, relates to the $42.3 million loss 
      recorded upon the exercise of the 2023 RDO and 2023 PIPE Warrants 
      (collectively, the "2023 Warrants") and issuance of the warrants in 2024 
      (the "2024 Warrants") in connection with the warrant exercise agreements 
      entered into on February 27, 2024 and March 4, 2024. This loss is net of 
      a $10.6 million gain related to the issuance of the 2024 Warrants and 
      was further offset by a reduction of $27.4 million upon remeasurement of 
      the 2024 Warrants and IPO Warrants' fair value during the nine months 
      ended September 30, 2024. The decrease in fair value of derivatives 
      during the three months ended September 30, 2024 relates to 
      remeasurement of the 2024 Warrants and IPO Warrants' fair value. 
(3)   During the three and nine months ended September 30, 2025 and September 
      30, 2024, the Company incurred employee separation costs associated with 
      a strategic review of the Company's capacity and future projections to 
      better align the organization and cost structure and improve the 
      affordability of its products and services. 
(4)   Non-recurring professional fees incurred in connection with discrete, 
      non-recurring strategic initiatives, including business transformation 
      and strategy realignment consulting services which management does not 
      consider part of the Company's ongoing operating expenses. 
(5)   Non-recurring litigation consists primarily of legal settlements and 
      related fees for specific proceedings that we have determined arise 
      outside of the ordinary course of business based on the following 
      considerations which we assess regularly: (1) the frequency of similar 
      cases that have been brought to date, or are expected to be brought 
      within two years; (2) the complexity of the case; (3) the nature of the 
      remedy(ies) sought, including the size of any monetary damages sought; 
      (4) offensive versus defensive posture of us; (5) the counterparty 
      involved; and (6) our overall litigation strategy. 
(6)   Transaction expenses during the nine months ended March 31, 2024 consist 
      primarily of diligence, legal and other related expenses incurred 
      associated with the Pangiam acquisition. 
(7)   Non-recurring internal integration costs related to the Pangiam 
      acquisition. 
(8)   During the three months ended March 31, 2024, the Company recognized a 
      non-cash goodwill impairment charge primarily driven by a decrease in 
      share price during the quarter compared to the share price of the equity 
      issued as consideration for the purchase of Pangiam. During the six 
      months ended June 30, 2025, the company recognized a non-cash goodwill 
      impairment charge of $70.6 million, primarily driven by a change in 
      forecast during the second quarter of 2025. 
(9)   Loss on extinguishment of debt is related to voluntary conversions of 
      the 2029 Notes to common stock and the related extinguishment of 
      unamortized debt discount and debt costs. 
 
*EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin are non-GAAP financial 
measures. See the "Non-GAAP Financial Measures" section in this press release 
for additional information and reconciliations. 
 
 
 
 

Forward-Looking Statements

This release contains forward-looking statements regarding future events and our future results that are subject to the safe harbors created under the Securities Act of 1933 (the "Securities Act"), the Securities Exchange Act of 1934 (the "Exchange Act") and the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect," "should," "would," "plan," "predict," "project," "potential," "seem," "seek," "future," "outlook," and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding our industry, future events, financial outlook, our business strategy and plans, our objectives for future operations, our planned acquisition of Ask Sage, Inc. and other statements that are not historical facts. These statements are based on current expectations and beliefs concerning future developments and their potential effects on us and should not be relied upon as representing BigBear's assessment as of any date subsequent to the date of this release. There can be no assurance that future developments affecting us will be those that we have anticipated. Many actual events and circumstances are beyond our control. These forward-looking statements are subject to a number of risks and uncertainties, including those relating to: changes in domestic and foreign business, market, financial, political, and legal conditions; the uncertainty of projected financial information; delays caused by factors outside of our control, including changes in fiscal or contracting policies or decreases in available government funding, including as a result of events such as war, incidents of terrorism, natural disasters, and public health concerns or epidemics; changes in government programs or applicable requirements; budgetary constraints, including any potential constraints as a result of recent or future federal government layoffs, including automatic reductions as a result of "sequestration" or similar measures and constraints imposed by any lapses in appropriations for the federal government or certain of its departments and agencies, including government shutdowns or the ability of the U.S. federal government to unilaterally cancel a contract with or without cause, and more specifically, the potential impact of the U.S. DOGE Service Temporary Organization on government spending and terminating contracts for convenience; the failure of contracts comprising backlog to result in revenue due to changes in funding, terminations for convenience, or option periods going unexercised; the impact of tariffs or other restrictive trade measures; implementation of spending limits or changes in budgetary constraints; influence by, or competition from, third parties with respect to pending, new, or existing contracts with government customers; changes in our ability to successfully compete for and receive task orders and generate revenue under Indefinite Delivery/Indefinite Quantity contracts; our ability to realize the benefits of the strategic partnerships; potential delays or changes in the government appropriations or procurement processes; our ability to remediate a material weakness in our internal control over financial reporting; risks regarding the market and our customers accepting and adopting our products, including future new product offerings; the high degree of uncertainty of the level of demand for, and market utilization of, our solutions and products; our ability to successfully execute and realize the benefits of joint ventures, channel sales relationships, partnerships, strategic alliances, subcontracting opportunities, customer contracts and other commercial agreements to which we are a party; failure to consummate the proposed transaction with Ask Sage; failure to satisfy closing conditions to the proposed transaction with Ask Sage; the potential impact of announcement or consummation of the proposed transaction with Ask Sage on relationships with third parties, including clients, employees and competitors; risks that the new businesses will not be integrated successfully or that the combined companies will not realize estimated cost savings; failure to realize anticipated benefits of the combined operations; and those factors discussed in the Company's reports and other documents filed with the SEC, including under the heading "Risk Factors." If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from those projected by these forward-looking statements. There may be additional risks that we presently do not know or that we currently believe are immaterial which could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect our expectations, plans or forecasts of future events and views as of the date of this release. We anticipate that subsequent events and developments will cause our assessments to change. However, we specifically disclaim any obligation to do so, except as may be required by law. Accordingly, undue reliance should not be placed upon the forward-looking statements.

Non-GAAP Financial Measures

The financial information and data contained in this press release is unaudited. Some of the financial information and data contained in this press release, such as EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin have not been prepared in accordance with United States generally accepted accounting principles ("GAAP"). To supplement our unaudited condensed consolidated financial statements, which are prepared and presented in accordance with GAAP in our press release, we also report certain non-GAAP financial measures. A "non-GAAP financial measure" refers to a numerical measure of a company's historical or future financial performance, financial position, or cash flows that excludes (or includes) amounts that are included in (or excluded from) the most directly comparable measure calculated and presented in accordance with GAAP in such company's financial statements. Non-GAAP financial measures should not be considered in isolation or as a substitute for the relevant GAAP measures and should be read in conjunction with information presented on a GAAP basis. Because not all companies use identical calculations, our presentation of non-GAAP measures may not be comparable to other similarly titled measures of other companies.

The presentation of these financial measures is not intended to be considered in isolation or as a substitute for, or superior to, financial information prepared and presented in accordance with GAAP and should not be considered measures of BigBear.ai's liquidity. Investors are cautioned that there are material limitations associated with the use of non-GAAP financial measures as an analytical tool. In particular, many of the adjustments to our GAAP financial measures reflect the exclusion of certain items, as defined in our non-GAAP definitions below, which are recurring and will be reflected in our financial results for the foreseeable future. In addition, these measures may be different from non-GAAP financial measures used by other companies, even where similarly titled, limiting their usefulness for comparison purposes and therefore should not be used to compare BigBear.ai's performance to that of other companies. We endeavor to compensate for the limitation of the non-GAAP financial measures presented by also providing the most directly comparable GAAP measures and descriptions of the reconciling items and adjustments to derive the non-GAAP financial

measures.

We believe these non-GAAP financial measures provide investors and analysts with useful supplemental information about the financial performance of our business, enable comparison of financial results between periods where certain items may vary independent of business performance, and allow for greater transparency with respect to key measures used by management to operate and analyze our business over different periods of time.

EBITDA is defined as net income (loss) before interest expense, interest income, income tax expense (benefit) and depreciation and amortization. Adjusted EBITDA is defined as EBITDA further adjusted for equity-based compensation, employer payroll taxes related to equity-based compensation, net increase in fair value of derivatives, restructuring charges, non-recurring strategic initiatives, non-recurring integration costs, non-recurring litigation, transaction expenses, goodwill impairment, and loss on extinguishment of debt.

Adjusted EBITDA Margin is defined as Adjusted EBITDA as a percentage of Revenue.

Similar excluded expenses may be incurred in future periods when calculating these measures. BigBear.ai believes these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to the Company's financial condition and results of operations. BigBear.ai believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating projected operating results and trends and in comparing BigBear.ai's financial measures with other similar companies, many of which present similar non-GAAP financial measures to investors.

Management does not consider these non-GAAP measures in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations as they reflect the exercise of judgment by management about which expense and income items are excluded or included in determining these non-GAAP financial measures.

Management uses EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin as non-GAAP performance measures which are reconciled to the most directly comparable GAAP measure, in the tables included in this release. The Company does not reconcile forward-looking non-GAAP financial measures to the most directly comparable GAAP financial measure (or otherwise describe such forward-looking GAAP measure) because it is not able to forecast the most directly comparable measure calculated and presented in accordance with GAAP without unreasonable effort. Certain elements of the composition of the GAAP amounts are not predictable, making it impracticable for the Company to forecast. As a result, no guidance for the Company's net (loss) income or reconciliation of the Company's Adjusted EBITDA guidance is provided. For the same reasons, the Company is unable to assess the probable significance of the unavailable information, which could have a potentially significant impact on its future net income (loss).

We present reconciliations of these non-GAAP financial measures to the most directly comparable GAAP measures in the tables included in this release.

About BigBear.ai

BigBear.ai is a leader in AI-powered decision intelligence solutions. Customers and partners rely on BigBear.ai's predictive analytics capabilities in highly complex, distributed, mission-based operating environments. Headquartered in McLean, Virginia, BigBear.ai is a public company traded on the NYSE under the symbol BBAI.

For more information, visit https://bigbear.ai/ and follow BigBear.ai on LinkedIn: @BigBear.ai and X: @BigBearai.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251110767674/en/

 
    CONTACT:    BigBear.ai 

investors@bigbear.ai

Media Contact

media@bigbear.ai

 
 

(END) Dow Jones Newswires

November 10, 2025 16:15 ET (21:15 GMT)

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10